CMS May Take Lead In Federal Compounding Oversight After Court Ruling
• By The Pink Sheet
The Centers for Medicare & Medicaid Services may serve as a stronger regulatory presence for pharmacy compounders in light of a recent federal court decision rejecting FDA's enforcement authority over the practice
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
